Skip to main content
Download PDF

Neuropsychological outcome after cardiac arrest: results from a sub-study of the targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest (TTM2) trial

Critical Care volume 27, Article number: 328 (2023) Cite this article

Abstract

Background

Cognitive impairment is common following out-of-hospital cardiac arrest (OHCA), but the nature of the impairment is poorly understood. Our objective was to describe cognitive impairment in OHCA survivors, with the hypothesis that OHCA survivors would perform significantly worse on neuropsychological tests of cognition than controls with acute myocardial infarction (MI). Another aim was to investigate the relationship between cognitive performance and the associated factors of emotional problems, fatigue, insomnia, and cardiovascular risk factors following OHCA.

Methods

This was a prospective case–control sub-study of The Targeted Hypothermia versus Targeted Normothermia after Out-of-Hospital Cardiac Arrest (TTM2) trial. Eight of 61 TTM2-sites in Sweden, Denmark, and the United Kingdom included adults with OHCA of presumed cardiac or unknown cause. A matched non-arrest control group with acute MI was recruited. At approximately 7 months post-event, we administered an extensive neuropsychological test battery and questionnaires on anxiety, depression, fatigue, and insomnia, and collected information on the cardiovascular risk factors hypertension and diabetes.

Results

Of 184 eligible OHCA survivors, 108 were included, with 92 MI controls enrolled. Amongst OHCA survivors, 29% performed z-score ≤ − 1 (at least borderline–mild impairment) in ≥ 2 cognitive domains, 14% performed z-score ≤ − 2 (major impairment) in ≥ 1 cognitive domain while 54% performed without impairment in any domain. Impairment was most pronounced in episodic memory, executive functions, and processing speed. OHCA survivors performed significantly worse than MI controls in episodic memory (mean difference, MD = − 0.37, 95% confidence intervals [− 0.61, − 0.12]), verbal (MD = − 0.34 [− 0.62, − 0.07]), and visual/constructive functions (MD = − 0.26 [− 0.47, − 0.04]) on linear regressions adjusted for educational attainment and sex. When additionally adjusting for anxiety, depression, fatigue, insomnia, hypertension, and diabetes, executive functions (MD = − 0.44 [− 0.82, − 0.06]) were also worse following OHCA. Diabetes, symptoms of anxiety, depression, and fatigue were significantly associated with worse cognitive performance.

Conclusions

In our study population, cognitive impairment was generally mild following OHCA. OHCA survivors performed worse than MI controls in 3 of 6 domains. These results support current guidelines that a post-OHCA follow-up service should screen for cognitive impairment, emotional problems, and fatigue.

Trial registration

ClinicalTrials.gov, NCT03543371. Registered 1 June 2018.

Background

The survival rate for adult out-of-hospital cardiac arrest (OHCA) is poor but has increased over the recent decades, with an estimated global 1-year survival rate of 7.7% [1]. This is associated with a growing need for follow-up of both the seen and unseen consequences after OHCA [2]. Circulatory standstill and the subsequent low-flow state that characterizes cardiac arrest results in an immediate interruption of oxygen supply and may lead to hypoxic-ischemic brain injury [3]. Cognitive impairments, especially in the cognitive domains of memory, attention/processing speed, and executive functioning, are reported in about half of survivors [4, 5]. However, these domains are the most thoroughly investigated and smaller studies indicate that verbal and visual/constructive functions could be affected too [6, 7]. Even mild cognitive impairment after OHCA can lead to reduced societal participation and major cognitive impairment has a substantial effect on daily function [8, 9]. An earlier study reported that cognitive impairment was common six months after OHCA but found only minor cognitive differences between OHCA survivors and a risk factor matched control group with acute ST-elevation myocardial infarction (STEMI) [10]. This earlier study mainly used screening tests and focused on a limited number of cognitive domains. Furthermore, OHCA is a risk factor for the development of emotional problems [11]. Brain injury and associated factors such as emotional problems, fatigue, and cardiovascular risk factors might also contribute to cognitive impairment post-cardiac arrest. However, the nature of cognitive impairment and the role of associated factors should be further investigated with more sensitive tests and comprehensive data.

Our aims in this study, using detailed neuropsychological tests of cognition, were to: provide detailed information on cognitive impairment in OHCA survivors at 7 months, compare the cognitive performance to a matched cohort of participants following acute myocardial infarction (MI) without cardiac arrest (and therefore without the risk of hypoxic-ischemic brain injury), and investigate the relationship between cognitive performance and the associated factors of emotional problems, fatigue, insomnia, and cardiovascular risk factors following OHCA. We hypothesized that OHCA survivors would perform significantly worse on the neuropsychological tests compared to MI controls.

Methods

Study design

This predefined case–control sub-study is a part of the international, multicenter Targeted Hypothermia versus Targeted Normothermia after Out-of-Hospital Cardiac Arrest (TTM2) trial [12, 13], in which 8 of 61 TTM2-sites participated. The study protocol has been published [14] and the study registered at ClinicalTrials.gov, NCT03543371.

Participants and procedure

In the TTM2-trial, comatose adult survivors of OHCA with a presumed cardiac or unknown cause were randomized to targeted hypothermia at 33 °C or targeted normothermia with early treatment of fever (core temperature ≤ 37.8 °C) [12, 13]. At the six-month TTM2-trial follow-up meeting [15], survivors at the selected sites in Sweden, Denmark, and the United Kingdom were invited to this sub-study that was performed as a separate face-to-face meeting. One site in each country was responsible for recruiting a non-arrest control group of participants with acute MI (STEMI and non-STEMI) who had undergone coronary angiography and appropriate revascularization. As earlier described [14], the MI controls were matched to date of cardiac event (± 4 weeks), sex, and age (best match) at an intended 1:1 ratio, and participated in a similar visit. Between July 2018 and January 2021, the sub-study was performed approximately 7 months post-cardiac event up to 12 months at the latest. In comparison to the TTM2-trial, additional exclusion criteria for this sub-study were age ≥ 80, a clinical diagnosis of major neurocognitive disorder (dementia) before the cardiac event, inability to speak the local language well enough to complete the assessment without assistance from an interpreter, inability to meet for a face-to-face examination, active drug abuse, and Clinical Frailty Scale Index ≥ 8, indicating very severe frailty [14, 16]. The TTM2-trial and this sub-study received approval by ethics committees in all participating countries. All included participants gave their written and oral informed consent.

Outcome assessments

Neuropsychological test battery Six cognitive domains were assessed, italicized below, based on the subsequent neuropsychological tests.

  • Verbal Wechsler Adult Intelligence Scale—Fourth Edition (WAIS-IV) Vocabulary [17], Delis-Kaplan Executive Function System (D-KEFS) Verbal Fluency [18].

  • Visual/constructive WAIS-IV Block Design, Matrix Reasoning [17].

  • Working memory WAIS-IV Digit Span [17], Wechsler Memory Scale – Third Edition (WMS-III) Spatial Span [19].

  • Episodic memory Rey Auditory Verbal Learning Test (RAVLT) [20], WMS-III Logical Memory [19], Brief Visuospatial Memory Test-Revised (BVMT-R) [21].

  • Processing speed Trail Making Test (TMT) A [22], D-KEFS Color-Word Interference Test (CWIT) 1 & 2 [18].

  • Executive functions TMT B [22], D-KEFS CWIT 3 [18].

Details on the neuropsychological tests are presented in the study protocol [14]. The raw scores were converted to z-scores according to age and, when available, education-based population norms. Negative z-scores reflect worse scores than the population mean. The z-scores of individual neuropsychological tests were combined to the 6 cognitive domains. For each domain a neuropsychological composite score was computed (z-scores with normative M = 0; SD = 1). Scores ≤ − 1 SD, equal to a z-score of ≤ − 1, are generally considered indicative of possible cognitive impairment [23]. Using classifications for mild and major neurocognitive disorder from the Diagnostic and Statistical Manual of Mental Disorders—5th Edition [23], we described z-scores ≤ − 1 as at least borderline–mild cognitive impairment, ≤ − 2 as major impairment, while z-scores > − 1 were considered without impairment.

Questionnaires on emotional problems, fatigue, and insomnia Before or after the visit, participants filled out questionnaires on self-reported symptoms within the subsequent areas. Emotional problems Hospital Anxiety and Depression Scale (HADS) with the anxiety (HADS-A) and depression (HADS-D) subscales [24]; fatigue Multidimensional Fatigue Inventory (MFI-20) with the five dimensions General fatigue, Physical fatigue, Reduced activity, Reduced motivation, and Mental fatigue [25]; insomnia Minimal Insomnia Symptom Scale (MISS) [26]. When available, cut-scores were used to describe possible clinical conditions (HADS-A and HADS-D: ≥ 8; MISS: ≥ 6) [24, 26]. Higher scores reflect more reported symptoms on all questionnaires.

Functional outcome Modified Rankin Scale (mRS) was the clinician-reported functional outcome measure assessed during the six-month TTM2-trial follow-up [27]. The scale ranges from 0 (no symptoms) to 6 (death).

Cardiovascular risk factors The MI controls answered questions about the cardiovascular risk factors hypertension (treatment yes/no) and diabetes (prevalence yes/no) at the time of examination. This information had already been collected from the OHCA survivors at the six-month TTM2-trial follow-up meeting.

Statistical analyses

Descriptive statistics for continuous data are presented as means and standard deviations or medians and quartiles 1–3, depending on the distribution of the data. Binary and categorical data are presented as count and percentages. To explore the profile of OHCA survivors with major impairment z ≤ − 2 in at least one of six neuropsychological composite scores, these OHCA survivors were compared to the remaining OHCA survivors with Wilcoxon Mann–Whitney U test or Fisher’s exact test in a sub-group analysis.

Effect sizes on the z-score based neuropsychological composite scores were calculated with Cohen’s d, and reported as follows: 0.2–0.49 = Small/slight; 0.5–0.79 = Moderate; > 0.8 = Strong [28]. Further between-group differences on the neuropsychological composite scores were investigated with linear regression. For each cognitive domain, analyses were performed in three steps and reported as the mean difference (equal to the slope β). As step 1, unadjusted regressions were performed. To examine our hypothesis according to the pre-specified analysis plan, the same analyses were repeated but adjusted for level of education (university education, yes/no) and sex (male/female) as step 2. Additional linear regression models were calculated as step 3 to adjust for factors that could be associated with cognitive impairment; level of education, sex, anxiety and depression (HADS-A and HADS-D), fatigue (the five MFI-20 dimensions), insomnia (MISS), hypertension, and diabetes.

Associations between anxiety, depression, fatigue, insomnia, hypertension, diabetes, functional outcome, and neuropsychological composite scores were calculated with Spearman’s rho. Associations were reported as follows: 0.1–0.29 = Small/slight; 0.3–0.49 = Moderate; > 0.5 = Large/high [28].

All tests were two-tailed, and results were considered statistically significant at p < 0.05. Analyses were performed with R 3.6.3 (R Foundation for Statistical Computing, Vienna, Austria) and SPSS Statistics 27 (IBM Corp, Armonk, NY, USA).

Results

Participants

A flow chart of the study inclusion can be found in Fig. 1. Of 184 eligible OHCA survivors, 108 were included in this study, together with 92 MI controls. The demographic and clinical characteristics of the included participants are reported in Table 1.

Fig. 1
figure 1

Flowchart of included out-of-hospital cardiac arrest survivors and acute myocardial infarction controls

Full size image
Table 1 Sociodemographic and medical background variables on all TTM2-survivors, included OHCA survivors, and included MI controls
Full size table

When comparing all 939 TTM2-survivors with the 108 included OHCA survivors, the median age was 60 vs 62, and 84% vs 88% were men. Of all TTM2-survivors, 33% had > 12 years of formal education as compared to 38% of included OHCA survivors. On the Montreal Cognitive Assessment (MoCA) that was used as a cognitive screening at six-months in the TTM2-trial, 41% of all TTM2-survivors and 34% of included OHCA survivors had scores < 26 indicating cognitive impairment [29]. Acute MI (STEMI and non-STEMI) was the cause of the initial cardiac arrest in 54% vs 57% of cases. For a detailed comparison, see Table 1.

Descriptive outcome on the neuropsychological tests

Performance without cognitive impairment on all six composite scores occurred among 54% of OHCA survivors and 63% of MI controls (Fig. 2a). Scores indicating at least borderline–mild impairment were most common in one single composite score in both OHCA survivors (17%) and MI controls (21%). At least borderline–mild impairment on two or more of the composite scores occurred in 29% of OHCA survivors and 16% of MI controls. Major cognitive impairment in one or more composite scores was observed in 14% of OHCA survivors and 4% of MI controls, see Fig. 2b.

Fig. 2
figure 2

Number of cognitive domains (0–6) with cognitive impairment in of out-of-hospital cardiac arrest (OHCA) survivors and myocardial infarction (MI) controls, n (%). At least borderline–mild impairment (z ≤ -1) in A, major impairment (z ≤ -2) in B. Key in the bottom

Full size image

The largest deficits, indicating at least borderline–mild impairment on the composite scores, were found in episodic memory (OHCA: 27%; MI: 13%) and executive functions (OHCA: 21%; MI: 11%), see Fig. 3a–f and Table 2. Major impairment was most frequently observed among OHCA survivors in executive functions (10%), processing speed (6%), and episodic memory (5%). Overall, MI controls performed similar to or better than the test score distribution according to population norms (Fig. 3g).

Fig. 3
figure 3

Result distribution on the neuropsychological composite scores (a–f) with of out-of-hospital cardiac arrest (OHCA) survivors and myocardial infarction (MI) controls, as well as assumed distribution in non-clinical groups according to population norms (g). Key with standard deviations (SD) on the lower right

Full size image
Table 2 Statistics on test performances in z-scores on the composite scores and associated neuropsychological tests
Full size table

On the individual neuropsychological tests used for composite score calculation, the greatest impairment amongst OHCA survivors was found on the episodic memory tests BVMT-R (total recall z ≤ − 1: 47%) and RAVLT (total recall z ≤ − 1: 34%), and the executive test TMT B (z ≤ − 1: 32%). See Table 2, and Additional file 1: Fig. S1 and Table S1.

In an exploratory subgroup analysis, OHCA survivors with major cognitive impairment in at least one of six composite scores (n = 15, 14%) had higher rates of diabetes (p = 0.03) and lower rates of bystander-performed cardiopulmonary resuscitation (p = 0.02) compared to the remaining included 93 OHCA survivors. OHCA survivors with major cognitive impairment had a longer intensive care unit (p = 0.001) and hospital (p < 0.001) stay. At the time of examination, they reported more symptoms of depression (p = 0.01) and fatigue (physical: p = 0.02; mental: p = 0.001; reduced activity: p < 0.001; reduced motivation: p = 0.002), and more frequently used psychotropic drugs (anxiolytics: p = 0.01; antidepressants: p = 0.004; sedatives/hypnotics: p = 0.02). Other sociodemographic, comorbidity, and prehospital variables were non-significant (Additional file 1: Table S2).

Comparative analyses of the neuropsychological tests in OHCA survivors and MI controls

The unadjusted regressions showed that OHCA survivors performed significantly worse than MI controls in the cognitive domain of episodic memory (step 1; Table 3). Here, between-group differences were non-significant in the other five cognitive domains. Effect sizes ranged from negligible (processing speed, working memory) to slight (episodic memory, visual/constructive, verbal, executive functions) (Table 2).

Table 3 Analyses of z-score based regression models for cognitive domain differences between OHCA survivors and MI controls
Full size table

In the main, pre-specified regressions adjusted for level of education and sex, OHCA survivors performed worse than MI controls in three of six cognitive domains: episodic memory, verbal, and visual/constructive functions (step 2; Table 3).

In the regressions adjusted for level of education, sex, anxiety, depression, fatigue, insomnia, hypertension, and diabetes, OHCA survivors performed worse than MI controls in 4 of 6 cognitive domains, now including executive functions as well (step 3; Table 3).

Descriptive outcome on the questionnaires

Levels of self-reported symptoms of anxiety, depression, fatigue, and insomnia are presented in Table 4. The proportion of results indicating possible anxiety (OHCA = 21%, MI = 26%) and depression (OHCA = 15%, MI = 17%) were similar between groups.

Table 4 Results on self-reported symptom questionnaires
Full size table

Associations between neuropsychological tests, questionnaires, cardiovascular risk factors, and functional outcome in OHCA survivors

Emotional problems Anxiety symptoms were slightly associated with worse executive functions (rs = − 0.21, p = 0.01). Depressive symptoms were moderately associated with worse executive functions (rs = − 0.37, p < 0.001) and slightly associated with worse processing speed (rs = − 0.27, p = 0.01).

Fatigue General fatigue was slightly associated with worse executive functions (rs = − 0.24, p = 0.01). Mental fatigue was slightly associated with worse episodic memory (rs = − 0.21, p = 0.03) and executive functions (rs = − 0.25, p = 0.01). Physical fatigue was slightly associated with worse processing speed (rs = − 0.26, p = 0.01) and executive functions (rs = − 0.24, p = 0.01).

Insomnia Insomnia symptoms were not significantly associated with neuropsychological test performance.

Cardiovascular risk factors Diabetes was slightly associated with worse working memory (rs = − 0.18, p = 0.03), visual/constructive (rs = − 0.23, p = 0.01) and executive functions (rs = − 0.22, p = 0.02), while hypertension was not significantly associated with neuropsychological test performance. See Additional file 1: Table S3.

Functional outcome The mRS was moderately associated with verbal functions (rs = − 0.35, p < 0.001), and slightly associated with episodic memory (rs = − 0.29, p = 0.01), visual/constructive and executive functions (rs = − 0.23, p = 0.02) (Additional file 1: Table S4).

Discussion

In this study, we describe detailed information on neuropsychological outcome following adult OHCA in the late recovery phase at approximately 7 months post-arrest, and in relation to MI controls. In addition, we explore the relationship between cognition and anxiety, depression, fatigue, insomnia, hypertension, and diabetes. Our hypothesis, that OHCA survivors would perform significantly worse on the neuropsychological tests compared to a matched control group with acute MI, was upheld for the verbal, visual/constructive, and episodic memory domains when adjusting for educational attainment and sex.

Although exceptions with lower impairment rates exist [30], most previous research reports that about half of OHCA survivors have long-term cognitive impairment [4, 5]. In our data, this number was less in the late recovery phase with 29% having at least borderline–mild impairment in two or more neuropsychological composite scores. Since 14% had major impairment in at least one composite score, cognitive impairment in the current study was in general, mild. Major cognitive impairment was most frequent in the cognitive domains of episodic memory, processing speed, and executive functions. This finding is consistent with the literature [5].

In the subgroup analysis, a prolonged length of hospital stay and diabetes were more common among OHCA survivors with major cognitive impairment than remaining OHCA survivors. Some OHCA survivors may exhibit major cognitive impairment related to the hypoxic-ischemic brain injury caused by the OHCA, in addition to underlying cardiovascular burden. This study cannot discriminate between pre-arrest cognitive function in diabetes and possible exacerbation in case of OHCA, so additional research is required to investigate these findings. Furthermore, psychotropic drug use, which was more frequent in this subgroup analysis, as well as risk factors associated with post-intensive care syndrome could also have an impact on cognition following OHCA [31, 32]. We did not analyze the data based on temperature allocation in the current study, as pre-specified [14]. This approach is supported by the fact that there were no significant differences in hypothermia and normothermia for mortality and neurocognitive outcome in the main TTM2-trial, which included a larger number and proportion of eligible participants [13, 33].

When comparing groups, worse episodic memory performance among OHCA survivors was evident in all analyses and worse than population norms, suggesting clinical relevance. This was also the most manifest difference between the OHCA and MI cohorts on effect size measures. The smaller group of OHCA survivors with major cognitive impairment might be driving the group-effect. Although just a slight effect when comparing the cohorts according to benchmarks [28], it could be considered large for those affected by impairment. A larger number of OHCA survivors had cognitive impairment compared to normative data on processing speed and executive measures, but this was surprisingly not reflected as significant between-group differences in the pre-specified adjusted regression models. When adjusting for associated factors (step 3), OHCA survivors performed worse than MI controls on the executive functions composite score. In contrast, the worse verbal and visual/constructive performance among OHCA survivors may not be of particular clinical significance since, overall, both groups performed similarly to population norms in these domains.

A recent study comparing cognitive outcome following OHCA and MI reported approximately six times higher rates of cognitive impairment after OHCA than MI [34], a more distinct between-group difference than in our study. This prior study was performed close to hospital discharge and hence closer to the cardiac event than the current study. Indeed, a prevalence of cognitive impairment up to 80–100% has been reported in the early stages of recovery after OHCA [35, 36]. Like other forms of acquired brain injury, the greatest cognitive improvement occurs during the first three months post-arrest [37]. It is probable that many OHCA survivors have an early cognitive impairment but that several survivors have improved in the late recovery phase. A previous study from our group conducted at approximately six months post-OHCA found deficits in memory and executive functions that were similar between OHCA survivors and MI controls, but processing speed was worse among OHCA survivors [10]. This differs from the worse memory scores among OHCA survivors, compared to MI controls, in the present study. The difference might be an effect of the improved general sensitivity of the tests in this study.

We also aimed to investigate the relationship between post-arrest cognitive functioning and associated factors. The proportion of results representing possible anxiety (21%) and depression (15%) among our OHCA survivors were somewhat lower than the pooled six-months prevalence in a recent meta-analysis (34% and 17%, respectively), but still higher than the estimated prevalence in the general population [11]. Our finding that cognitive impairment was associated with symptoms of anxiety, depression, and fatigue following OHCA is in line with previous research [8, 38]. Worse executive functions were particularly related to emotional problems. The relationship between emotional problems and the neuropsychological test profile is in accordance with what has been observed in mood disorders without OHCA [39, 40]. Furthermore, mental fatigue was associated with deficits in episodic memory and executive functions. This is in agreement with some earlier acquired brain injury studies [41, 42]. Unlike hypertension, diabetes was significantly related to cognitive performance, which is consistent with a growing body of evidence indicating that diabetes impairs cognition over and above the burden of cerebrovascular pathology [43].

The interplay between cognition and the associated factors is complex. Mood disorders may partly predispose individuals to an OHCA by contributing to risk factors such as cardiovascular disease and diabetes [44], which in turn are associated with a higher probability of cognitive decline [45, 46]. Following OHCA, cognitive impairment is associated with depressive symptoms [8]. Meanwhile, post-arrest patient-reported cognitive complaints may represent emotional problems rather than cognitive decline [47]. Sleep disturbances might be symptoms of depression, and both could lead to sub-optimal cognitive performance [48], so awareness of all these interactions is essential to provide appropriate treatment.

The concise, clinician-reported mRS is currently recommended to assess functional outcome after OHCA in clinical trials [27, 49]. Earlier studies have reported correlations between clinician-reported outcome and performance-based cognitive tests such as neuropsychological tests [47, 50]. The measures are not directly comparable [49, 51], as again reflected by our results. Correspondingly, neuropsychological tests are sensitive for detecting clinical signs of hypoxic-ischemic brain injury that global outcome measures such as the mRS may overlook.

We used composite scores to form the cognitive domains, a common practice in earlier neuropsychological studies on OHCA survivors [52,53,54]. Composite scores reduce the number of variables but also decrease granularity, as the individual neuropsychological tests measure different sub-components of the same overall cognitive domain. For instance, even though we used composite classifications and tests previously administered to this population [53, 55,56,57], 21% of OHCA survivors performed to a level consistent with major cognitive impairment on the TMT B while only 9% obtained these scores on the D-KEFS CWIT 3. Cognitive flexibility (TMT B) may be more impaired than inhibition (CWIT 3) among OHCA survivors. Since TMT B and CWIT 3 both form the executive functions composite score, it is possible that the inclusion of the CWIT in the test battery has obscured OHCA-related executive impairment in our study.

As for clinical importance, the detailed data from this study may be used to guide measurement selection in clinical practice and research, considering the growing need for standardization in measures of neurocognitive function following OHCA [5, 58]. For example, the BVMT-R, RAVLT, and TMT were sensitive tests and could be candidate measures for a future neuropsychological test battery post-arrest. Moreover, our results highlight that cognitive, emotional, and fatigue screenings are all vital to identify impairment and distress in routine post-arrest follow-up, in line with current European guidelines [59]. Individuals with indicated impairment might benefit from a comprehensive evaluation with more sensitive measures. If necessary, treatment of emotional problems and fatigue management should be considered [60, 61], or patient-centered cognitive rehabilitation in memory, executive functioning, and attention/processing speed. These cognitive domains were the most affected in our study and seem to be predominantly impaired in the early stages of post-arrest recovery as well [37, 62]. Future work may additionally address the interplay between cognitive outcome, emotional problems, fatigue, cardiovascular risk factors, neuroimaging, and overall functional outcome in everyday life. Cognitive change over time should also be further investigated.

As for strengths of the study, we selected neuropsychological tests with high sensitivity when administered to OHCA survivors in previous research, added them to form an extensive test battery, and collected information on emotional problems, fatigue, insomnia, and cardiovascular risk factors. This generated a detailed outline of the post-OHCA neuropsychological profile, compared to the much used but less sensitive screening measures. A relatively large number of OHCA survivors and a matched control group were included, enabling comparisons with the general population through population norms and a group with similar cardiovascular risk factors.

There were important limitations to this study. Since only arrests of presumed cardiac or unknown causes were included in the TTM2-trial, our participants are not representative of all OHCA survivors. This could hamper study generalizability. As a sub-study of a large trial, we were able to compare our included OHCA survivors with all TTM2-survivors, increasing the internal validity of our study. Fewer included survivors had an indicated cognitive impairment on the MoCA than all TTM2-survivors, suggesting that OHCA survivors with cognitive impairment may be underrepresented in this study. Moreover, 57% of the OHCA survivors had acute MI as cause of arrest, while the MI controls had all suffered acute MI. We did also not accomplish a perfect 1:1 OHCA–MI ratio since the COVID-19 pandemic halted clinical research at all study sites at some time-points, and the matching of MI controls was based by country and not by site due to pragmatic reasons. However, the OHCA and MI cohorts were relatively equivalent in size and demographic variables. In addition, there are different standards of life support interventions depending on country of OHCA, and our results may only be translated to countries with similar intervention traditions as the three countries in our study. Another limitation is not having information on premorbid cognitive status. It is particularly difficult to compare our binary classifications of cognitive impairment with population norms since we do not have population-based information on between-test correlations when involving multiple cognitive domains; some results need to be interpreted with caution due to multiple comparisons. Whilst many participants performed without impairment, we cannot exclude that some impaired scores represent low premorbid capacities. We however used level of education as a proxy for premorbid cognitive functioning in the regression analyses, as educational duration is positively correlated with premorbid intellectual capacity [63]. Most of the individual neuropsychological scores, and all composite scores since they lack prior validation, do not have established anchor-based values for minimally important differences. Relatedly, the criterion for cognitive impairment varies between studies [5, 64]. To mitigate this, we have described cognitive impairment according to established classifications [23], and reported raw scores to facilitate comparability between studies.

Conclusions

Cognitive impairment assessed by neuropsychological tests was generally mild among OHCA survivors in our study population, but could in some cases be severe and extend over multiple cognitive domains. Our hypothesis that OHCA survivors would perform worse than MI controls was confirmed. Diabetes and symptoms of anxiety, depression, and fatigue were associated with worse cognitive performance among the OHCA survivors. The most sensitive tests used in this detailed examination could guide future assessments in both clinical practice and research settings.

Availability of data and materials

The data that will support the findings of this study are available from the TTM2-trial steering group, but restrictions apply to the availability of these data, and so are not publicly available. Data are however available from the authors upon reasonable request and with permission of the TTM2-trial steering group.

Abbreviations

BVMT-R:

Brief Visuospatial Memory Test-Revised

CWIT:

Color-Word Interference Test

D-KEFS:

Delis-Kaplan Executive Function System

HADS:

Hospital Anxiety and Depression Scale

MD:

Mean difference

MI:

Myocardial infarction

MFI-20:

Multidimensional Fatigue Inventory

MISS:

Minimal Insomnia Symptom Scale

MoCA:

Montreal Cognitive Assessment

mRS:

Modified Rankin Scale

OHCA:

Out-of-hospital cardiac arrest

RAVLT:

Rey Auditory Verbal Learning Test

STEMI:

ST-elevation myocardial infarction

TMT:

Trail Making Test

TTM2:

Targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest trial

WAIS-IV:

Wechsler Adult Intelligence Scale—Fourth Edition

WMS-III:

Wechsler Memory Scale—Third Edition

References

  1. Yan S, Gan Y, Jiang N, Wang R, Chen Y, Luo Z, Zong Q, Chen S, Lv C. The global survival rate among adult out-of-hospital cardiac arrest patients who received cardiopulmonary resuscitation: a systematic review and meta-analysis. Crit Care. 2020;24(1):61.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Boyce LW, Goossens PH. Rehabilitation after cardiac arrest: integration of neurologic and cardiac rehabilitation. Semin Neurol. 2017;37(01):094–102.

    Article  Google Scholar 

  3. Sandroni C, Cronberg T, Sekhon M. Brain injury after cardiac arrest: pathophysiology, treatment, and prognosis. Intensive Care Med. 2021;47(12):1393–414.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Moulaert VRMP, Verbunt JA, van Heugten CM, Wade DT. Cognitive impairments in survivors of out-of-hospital cardiac arrest: a systematic review. Resuscitation. 2009;80(3):297–305.

    Article  PubMed  Google Scholar 

  5. Zook N, Voss S, Blennow Nordström E, Brett SJ, Jenkinson E, Shaw P, White P, Benger J. Neurocognitive function following out-of-hospital cardiac arrest: a systematic review. Resuscitation. 2022;170:238–46.

    Article  PubMed  Google Scholar 

  6. Peskine A, Rosso C, Picq C, Caron E, Pradat-Diehl P. Neurological sequelae after cerebral anoxia. Brain Inj. 2010;24(5):755–61.

    Article  CAS  PubMed  Google Scholar 

  7. van Alem AP, de Vos R, Schmand B, Koster RW. Cognitive impairment in survivors of out-of-hospital cardiac arrest. Am Heart J. 2004;148(3):416–21.

    Article  PubMed  Google Scholar 

  8. Lilja G, Nielsen N, Bro-Jeppesen J, Dunford H, Friberg H, Hofgren C, Horn J, Insorsi A, Kjaergaard J, Nilsson F, et al. Return to work and participation in society after out-of-hospital cardiac arrest. Circ Cardiovasc Qual Outcomes. 2018;11(1): e003566.

    Article  PubMed  Google Scholar 

  9. Middelkamp W, Moulaert VR, Verbunt JA, van Heugten CM, Bakx WG, Wade DT. Life after survival: long-term daily life functioning and quality of life of patients with hypoxic brain injury as a result of a cardiac arrest. Clin Rehabil. 2007;21(5):425–31.

    Article  PubMed  Google Scholar 

  10. Lilja G, Nielsen N, Friberg H, Horn J, Kjaergaard J, Nilsson F, Pellis T, Wetterslev J, Wise MP, Bosch F, et al. Cognitive function in survivors of out-of-hospital cardiac arrest after target temperature management at 33 degrees C versus 36 degrees C. Circulation. 2015;131(15):1340–9.

    Article  PubMed  Google Scholar 

  11. Yaow CYL, Teoh SE, Lim WS, Wang RSQ, Han MX, Pek PP, Tan BY-Q, Ong MEH, Ng QX, Ho AFW. Prevalence of anxiety, depression, and post-traumatic stress disorder after cardiac arrest: a systematic review and meta-analysis. Resuscitation. 2022;170:82–91.

    Article  PubMed  Google Scholar 

  12. Dankiewicz J, Cronberg T, Lilja G, Jakobsen JC, Bělohlávek J, Callaway C, Cariou A, Eastwood G, Erlinge D, Hovdenes J, et al. Targeted hypothermia versus targeted Normothermia after out-of-hospital cardiac arrest (TTM2): a randomized clinical trial—rationale and design. Am Heart J. 2019;217:23–31.

    Article  PubMed  Google Scholar 

  13. Dankiewicz J, Cronberg T, Lilja G, Jakobsen JC, Levin H, Ullén S, Rylander C, Wise MP, Oddo M, Cariou A, et al. Hypothermia versus normothermia after out-of-hospital cardiac arrest. N Engl J Med. 2021;384(24):2283–94.

    Article  PubMed  Google Scholar 

  14. Blennow Nordström E, Lilja G, Vestberg S, Ullén S, Friberg H, Nielsen N, Heimburg K, Evald L, Mion M, Segerström M, et al. Neuropsychological outcome after cardiac arrest: a prospective case control sub-study of the Targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest trial (TTM2). BMC Cardiovasc Disord. 2020;20(1):439.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Lilja G, Nielsen N, Ullen S, Blennow Nordstrom E, Dankiewicz J, Friberg H, Heimburg K, Jakobsen JC, Levin H, Callaway C, et al. Protocol for outcome reporting and follow-up in the targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest trial (TTM2). Resuscitation. 2020;150:104–12.

    Article  PubMed  Google Scholar 

  16. Rockwood K, Song X, MacKnight CB, Howard HDB, McDowell I, Mitnitski A. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173(5):489–95.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Wechsler D. Wechsler adult intelligence scale—fourth edition (WAIS-IV). San Antonio: Pearson Assessment; 2008.

    Google Scholar 

  18. Delis DC, Kaplan E, Kramer JH. Delis–Kaplan executive function system (D-KEFS). San Antonio: The Psychological Corporation; 2001.

    Google Scholar 

  19. Wechsler D. Wechsler memory scale—third edition (WMS-III). San Antonio: The Psychological Corporation; 1997.

    Google Scholar 

  20. Rey A. Rey auditory verbal learning test (RAVLT): Western psychological services; 1958.

  21. Benedict RH. Brief visuospatial memory test—revised (BVMT-R). Odessa: Psychological Assessment Resources, Inc; 1997.

    Google Scholar 

  22. Reitan RM. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills. 1958;8:271–6.

    Article  Google Scholar 

  23. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Association; 2013.

    Book  Google Scholar 

  24. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.

    Article  CAS  PubMed  Google Scholar 

  25. Smets EMA, Garssen B, Bonke B, De Haes JCJM. The multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39(3):315–25.

    Article  CAS  PubMed  Google Scholar 

  26. Broman J-E, Smedje H, Mallon L, Hetta J. The Minimal Insomnia Symptom Scale (MISS). Upsala J Med Sci. 2008;113(2):131–42.

    Article  PubMed  Google Scholar 

  27. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke J Cereb Circ. 1988;19(5):604–7.

    Article  Google Scholar 

  28. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: L. Erlbaum Associates; 1988.

    Google Scholar 

  29. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9.

    Article  PubMed  Google Scholar 

  30. Evald L, Brønnick K, Duez CHV, Grejs AM, Jeppesen AN, Søreide E, Kirkegaard H, Nielsen JF. Prolonged targeted temperature management reduces memory retrieval deficits six months post-cardiac arrest: a randomised controlled trial. Resuscitation. 2019;134:1–9.

    Article  PubMed  Google Scholar 

  31. Meador KJ. Cognitive side effects of medications. Neurol Clin. 1998;16(1):141–55.

    Article  CAS  PubMed  Google Scholar 

  32. Rousseau A-F, Prescott HC, Brett SJ, Weiss B, Azoulay E, Creteur J, Latronico N, Hough CL, Weber-Carstens S, Vincent J-L, et al. Long-term outcomes after critical illness: recent insights. Crit Care. 2021;25(1):108.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Lilja G, Ullén S, Dankiewicz J, Friberg H, Levin H, Blennow Nordström E, Heimburg K, Jakobsen JC, Ahlqvist M, Bass F et al. Effects of hypothermia vs normothermia on societal participation and cognitive function at 6 months in survivors after out-of-hospital cardiac arrest: a predefined analysis of the TTM2 randomized clinical trial. JAMA Neurol. 2023.

  34. Byron-Alhassan A, Collins B, Bedard M, Quinlan B, Le May M, Duchesne L, Osborne C, Wells G, Smith AM, Tulloch HE. Cognitive dysfunction after out-of-hospital cardiac arrest: rate of impairment and clinical predictors. Resuscitation. 2021;165:154–60.

    Article  PubMed  Google Scholar 

  35. Mion M, Magee N, Davis J, Farrell K, Nikolopoulou E, Jessup D, Davies J, Karamasis G, Keeble T. Exploring cognitive impairment in the early stages of an out-of-hospital cardiac arrest—a consecutive case series study. Neuropsychol Rehab. 2022;25:1–18.

    Google Scholar 

  36. Polanowska K, Sarzyńska-Długosz I, Paprot A, Sikorska Ś, Seniów J, Karpiński G, Kowalik R, Opolski G, Członkowska A. Neuropsychological and neurological sequelae of out-of-hospital cardiac arrest and the estimated need for neurorehabilitation: a prospective pilot study. Kardiol Polska (Pol Heart J). 2014;72(9):814–22.

    Article  Google Scholar 

  37. Steinbusch CVM, van Heugten CM, Rasquin SMC, Verbunt JA, Moulaert VRM. Cognitive impairments and subjective cognitive complaints after survival of cardiac arrest: a prospective longitudinal cohort study. Resuscitation. 2017;120(Supplement C):132–7.

    Article  PubMed  Google Scholar 

  38. Lilja G, Nilsson G, Nielsen N, Friberg H, Hassager C, Koopmans M, Kuiper M, Martini A, Mellinghoff J, Pelosi P, et al. Anxiety and depression among out-of-hospital cardiac arrest survivors. Resuscitation. 2015;97:68–75.

    Article  CAS  PubMed  Google Scholar 

  39. Hammar Å, Ronold EH, Rekkedal GÅ. Cognitive impairment and neurocognitive profiles in major depression—a clinical perspective. Front Psychiatry. 2022;1:3.

    Google Scholar 

  40. Castaneda AE, Tuulio-Henriksson A, Marttunen M, Suvisaari J, Lönnqvist J. A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults. J Affect Disord. 2008;106(1):1–27.

    Article  PubMed  Google Scholar 

  41. Ã…kerlund E, Sunnerhagen KS, Persson HC. Fatigue after acquired brain injury impacts health-related quality of life: an exploratory cohort study. Sci Rep. 2021;11(1):22153.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Johansson B. Mental fatigue after mild traumatic brain injury in relation to cognitive tests and brain imaging methods. Int J Environ Res Public Health. 2021;18(11):5955.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Hadley G, Zhang J, Harris-Skillman E, Alexopoulou Z, DeLuca GC, Pendlebury ST. Cognitive decline and diabetes: a systematic review of the neuropathological correlates accounting for cognition at death. J Neurol Neurosurg Psychiatry. 2022;93(3):246.

    Article  PubMed  Google Scholar 

  44. Batelaan NM, Seldenrijk A, van den Heuvel OA, van Balkom AJLM, Kaiser A, Reneman L, Tan HL. Anxiety, mental stress, and sudden cardiac arrest: epidemiology, possible mechanisms and future research. Front Psychiatry. 2022;12:813518.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Cheng G, Huang C, Deng H, Wang H. Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern Med J. 2012;42(5):484–91.

    Article  CAS  PubMed  Google Scholar 

  46. Qiu C, Fratiglioni L. A major role for cardiovascular burden in age-related cognitive decline. Nat Rev Cardiol. 2015;12(5):267–77.

    Article  PubMed  Google Scholar 

  47. Blennow Nordström E, Lilja G, Ullén S, Blennow K, Friberg H, Hassager C, Kjærgaard J, Mattsson-Carlgren N, Moseby-Knappe M, Nielsen N, et al. Serum neurofilament light levels are correlated to long-term neurocognitive outcome measures after cardiac arrest. Brain Inj. 2022;36(6):800–9.

    Article  PubMed  Google Scholar 

  48. Kennedy SH. Core symptoms of major depressive disorder: relevance to diagnosis and treatment. Dialogues Clin Neurosci. 2008;10(3):271–7.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Haywood K, Whitehead L, Nadkarni VM, Achana F, Beesems S, Böttiger BW, Brooks A, Castrén M, Ong MEH, Hazinski MF, et al. COSCA (core outcome set for cardiac arrest) in adults: an advisory statement from the international liaison committee on resuscitation. Circulation. 2018;137(22):e783–801.

    Article  PubMed  Google Scholar 

  50. Fugate JE, Moore SA, Knopman DS, Claassen DO, Wijdicks EF, White RD, Rabinstein AA. Cognitive outcomes of patients undergoing therapeutic hypothermia after cardiac arrest. Neurology. 2013;81(1):40–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Braun RG, Heitsch L, Cole JW, Lindgren AG, de Havenon A, Dude JA, Lohse KR, Cramer SC, Worrall BB. Domain-specific outcomes for stroke clinical trials: what the modified Rankin isn’t ranking. Neurology. 2021;97(8):367–77.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Alexander MP, Lafleche G, Schnyer D, Lim C, Verfaellie M. Cognitive and functional outcome after out of hospital cardiac arrest. J Int Neuropsychol Soc. 2011;17(02):364–8.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Juan E, De Lucia M, Beaud V, Oddo M, Rusca M, Viceic D, Clarke S, Rossetti AO. How do you feel? Subjective perception of recovery as a reliable surrogate of cognitive and functional outcome in cardiac arrest survivors. Crit Care Med. 2018;46(4):e286–93.

    Article  PubMed  Google Scholar 

  54. Lim C, Verfaellie M, Schnyer D, Lafleche G, Alexander MP. Recovery, long-term cognitive outcome and quality of life following out-of-hospital cardiac arrest. J Rehabil Med. 2014;46(7):691–7.

    Article  PubMed  Google Scholar 

  55. Mateen FJ, Josephs KA, Trenerry MR, Felmlee-Devine MD, Weaver AL, Carone M, White RD. Long-term cognitive outcomes following out-of-hospital cardiac arrest: a population-based study. Neurology. 2011;77(15):1438–45.

    Article  CAS  PubMed  Google Scholar 

  56. Ørbo M, Aslaksen PM, Larsby K, Schäfer C, Tande PM, Anke A. Alterations in cognitive outcome between 3 and 12 months in survivors of out-of-hospital cardiac arrest. Resuscitation. 2016;105:92–9.

    Article  PubMed  Google Scholar 

  57. Tiainen M, Poutiainen E, Oksanen T, Kaukonen K-M, Pettilä V, Skrifvars M, Varpula T, Castrén M. Functional outcome, cognition and quality of life after out-of-hospital cardiac arrest and therapeutic hypothermia: data from a randomized controlled trial. Scand J Trauma Resusc Emerg Med. 2015;23(1):12.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Haywood KL, Dainty KN, Swartz R. The what, when, how and who of neurocognitive function: the importance of assessment quality and community engagement. Resuscitation. 2022;170:247–9.

    Article  PubMed  Google Scholar 

  59. Nolan JP, Sandroni C, Böttiger BW, Cariou A, Cronberg T, Friberg H, Genbrugge C, Haywood K, Lilja G, Moulaert VRM, et al. European Resuscitation Council and European Society of Intensive Care Medicine Guidelines 2021: post-resuscitation care. Resuscitation. 2021;161:220–69.

    Article  PubMed  Google Scholar 

  60. Mion M, Case R, Smith K, Lilja G, Blennow Nordström E, Swindell P, Nikolopoulou E, Davis J, Farrell K, Gudde E, et al. Follow-up care after out-of-hospital cardiac arrest: a pilot study of survivors and families’ experiences and recommendations. Resuscitation Plus. 2021;7: 100154.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Moulaert VRM, van Heugten CM, Winkens B, Bakx WGM, de Krom MCFTM, Gorgels TPM, Wade DT, Verbunt JA. Early neurologically-focused follow-up after cardiac arrest improves quality of life at one year: a randomised controlled trial. Int J Cardiol. 2015;193:8–16.

    Article  PubMed  Google Scholar 

  62. Sabedra AR, Kristan J, Raina K, Holm MB, Callaway CW, Guyette FX, Dezfulian C, Doshi AA, Rittenberger JC. Neurocognitive outcomes following successful resuscitation from cardiac arrest. Resuscitation. 2015;90:67–72.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Ritchie SJ, Tucker-Drob EM. How much does education improve intelligence? A meta-analysis. Psychol Sci. 2018;29(8):1358–69.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Blennow Nordstrom E, Lilja G. Assessment of neurocognitive function after cardiac arrest. Curr Opin Crit Care. 2019;25(3):234–9.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank Occupational Therapist and Associate Professor Lisa Gregersen Østergaard (Aarhus University Hospital and Aarhus University, Aarhus, Denmark) and Clinical Nurse Specialist Helen Hill for additional participant recruitment and project administration (University Hospital of Wales, Cardiff, UK), Registered Nurse and Swedeheart Registry Monitor Ewa Mattsson for project administration (Skane University Hospital, Lund, Sweden), former Psychology Assistant JuliaAgnes Svensson and Neuropsychologist Anna Karin Thulin for conducting some of the neuropsychological examinations (Skane University Hospital, Lund, Sweden).

Funding

Open access funding provided by Lund University. This study was supported by The Skane University Hospital Foundations, The Skane University Hospital Psychology Research and Development Grant, The Hans-Gabriel and Alice Trolle-Wachtmeister Foundation for Medical Research, The Swedish Neuropsychological Society Research Grant, and The Royal Physiographic Society of Lund. The funding bodies had no role in the design of the study, data collection, analysis, or interpretation of data or in writing the manuscript.

Author information

Authors and Affiliations

  1. Neurology, Department of Clinical Sciences Lund, Skane University Hospital, Lund University, Lund, Sweden

    Erik Blennow Nordström, Katarina Heimburg, Hanna Ljung, Tobias Cronberg & Gisela Lilja

  2. Department of Psychology, Lund University, Lund, Sweden

    Susanna Vestberg

  3. Hammel Neurorehabilitation Centre and University Research Clinic, Hammel, Denmark

    Lars Evald

  4. Essex Cardiothoracic Centre, Mid and South Essex NHS Foundation Trust, Basildon, UK

    Marco Mion & Thomas R. Keeble

  5. Medical Technology Research Centre, Anglia Ruskin School of Medicine, Chelmsford, UK

    Marco Mion & Thomas R. Keeble

  6. Department of Neurology and Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden

    Magnus Segerström

  7. Clinical Studies Sweden – Forum South, Skane University Hospital, Lund, Sweden

    Susann Ullén

  8. Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark

    John Bro-Jeppesen

  9. Intensive and Perioperative Care, Department of Clinical Sciences Lund, Skane University Hospital, Lund University, Malmö, Sweden

    Hans Friberg & Johan Undén

  10. Department of Intensive Care Medicine and Department of Clinical Medicine, Aarhus University Hospital and Aarhus University, Aarhus, Denmark

    Anders M. Grejs

  11. Research Centre for Emergency Medicine, Emergency Department and Department of Clinical Medicine, Aarhus University Hospital and Aarhus University, Aarhus, Denmark

    Hans Kirkegaard

  12. Clinical Psychology, Cardiff and Vale University Health Board, NHS Wales, Cardiff, UK

    Sofia Rose

  13. Adult Critical Care, University Hospital of Wales, Cardiff, UK

    Matthew P. Wise

  14. Anaesthesiology and Intensive Care Medicine, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden

    Christian Rylander

  15. Operation and Intensive Care, Hallands Hospital Halmstad, Halmstad, Sweden

    Johan Undén

  16. Anesthesiology and Intensive Care, Department of Clinical Sciences Lund, Helsingborg Hospital, Lund University, Lund, Sweden

    Niklas Nielsen

Authors
  1. Erik Blennow Nordström
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Susanna Vestberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lars Evald
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marco Mion
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Magnus Segerström
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Susann Ullén
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. John Bro-Jeppesen
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hans Friberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Katarina Heimburg
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Anders M. Grejs
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Thomas R. Keeble
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Hans Kirkegaard
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Hanna Ljung
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Sofia Rose
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Matthew P. Wise
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Christian Rylander
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Johan Undén
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Niklas Nielsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Tobias Cronberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. Gisela Lilja
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

EBN, GL, SV, TC, and NN designed the study. EBN was the principal investigator and performed statistical analyses. EBN, TC, GL, SV, SU, KH, NN, and HF were the coordinating team. CR, HK, and MPW were national investigators. JBJ, LE, AMG, TRK, MM, SR, MS, and JU were site investigators. EBN, LE, HL, MM, SR, and MS performed the neuropsychological examinations. SU was the study statistician. EBN, GL, SV, and TC wrote the first draft. All authors were involved in critical revision for important intellectual content and gave final approval to the manuscript.

Corresponding author

Correspondence to Erik Blennow Nordström.

Ethics declarations

Ethics approval and consent to participate

The TTM2-trial and this sub-study received approval by Ethics Commissions in all participating countries. Written informed consent to participate in the sub-study was obtained before or at the sub-study examination by the study examiners.

Consent for publication

Not applicable.

Competing interests

The authors report no competing interests with respect to the research, authorship, and/or publication of this article.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1. Figure S1

. Result distribution on the neuropsychological tests. Table S1. Raw and standardized scores on the neuropsychological measures used for cognitive domain calculation. Table S2. Exploratory analyses on demographic and medical background variables for survivors with major cognitive impairment and survivors without major cognitive impairment. Table S3. Correlation matrix on neuropsychological composite scores and emotional problems, fatigue, and cardiovascular risk factors. Table S4. Spearman associations for neuropsychological composite scores and modified Rankin Scale scores.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Blennow Nordström, E., Vestberg, S., Evald, L. et al. Neuropsychological outcome after cardiac arrest: results from a sub-study of the targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest (TTM2) trial. Crit Care 27, 328 (2023). https://0-doi-org.brum.beds.ac.uk/10.1186/s13054-023-04617-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://0-doi-org.brum.beds.ac.uk/10.1186/s13054-023-04617-0

Keywords

Critical Care

ISSN: 1364-8535